Jinyu Bio (China) Today
| 600201 Stock | 6.46 0.06 0.92% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Jinyu Bio is trading at 6.46 as of the 18th of January 2025, a 0.92 percent decrease since the beginning of the trading day. The stock's open price was 6.52. Jinyu Bio has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 18th of January 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 24th of November 1998 | Category Healthcare | Classification Health Care |
Jinyu Bio is entity of China. It is traded as Stock on SHG exchange. The company has 1.12 B outstanding shares. More on Jinyu Bio Technology Co
Moving against Jinyu Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Jinyu Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Jinyu Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Jinyu Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Vice President | Rong Li | ||||
| Thematic Idea | Computers (View all Themes) | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Computers, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Computing (View all Sectors) | ||||
Jinyu Bio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Jinyu Bio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsJinyu Bio can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Jinyu Bio's financial leverage. It provides some insight into what part of Jinyu Bio's total assets is financed by creditors.
| |||||
Jinyu Bio Technology Co (600201) is traded on Shanghai Stock Exchange in China and employs 1,654 people. Jinyu Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jinyu Bio's market, we take the total number of its shares issued and multiply it by Jinyu Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Jinyu Bio Technology operates under Biotechnology sector and is part of Health Care industry. The entity has 1.12 B outstanding shares.
Jinyu Bio generates positive cash flow from operations, but has no cash available
Check Jinyu Bio Probability Of Bankruptcy
Ownership AllocationJinyu Bio Technology Co has a total of 1.12 Billion outstanding shares. Jinyu Bio retains 19.88 (percent) of its outstanding shares held by insiders and 12.03 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Jinyu Ownership Details
Jinyu Bio Technology Risk Profiles
Although Jinyu Bio's alpha and beta are two of the key measurements used to evaluate Jinyu Bio's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.55 | |||
| Semi Deviation | 2.13 | |||
| Standard Deviation | 2.12 | |||
| Variance | 4.49 |
Jinyu Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Jinyu Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Jinyu Bio Corporate Executives
Elected by the shareholders, the Jinyu Bio's board of directors comprises two types of representatives: Jinyu Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jinyu. The board's role is to monitor Jinyu Bio's management team and ensure that shareholders' interests are well served. Jinyu Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jinyu Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Other Information on Investing in Jinyu Stock
Jinyu Bio financial ratios help investors to determine whether Jinyu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jinyu with respect to the benefits of owning Jinyu Bio security.